WCMC-Q sheds light diabetes drug structureResearchers at Weill Cornell Medical College in Qatar (WCMC-Q) have shed light on the molecular and cellular mechanisms of one of the most widely used diabetes drugs, which have been poorly understood for more than 50 years. Exper More… |
Studies conflict on Glaxo diabetes drug riskTwo studies conducted in the US reported serious heart risks with GlaxoSmithKline Plc's diabetes pill Avandia while a third contradicted those findings, adding to a debate over whether the drug should stay on the market. The conflictin More… |